Literature DB >> 984043

A new pyruvate kinase variant (PK Osaka) demonstrated by partial purification and condensation.

K Shinohara, S Miwa, K Nakashima, E Oda, T Kageoka.   

Abstract

A qualitative variant of erythrocyte and liver pyruvate kinases (PK Osaka) was detected in a family in which two siblings have extremely low PK activity by semipurification with DEAE cellulose chromatography and subsequent concentration of the enzyme solutions. This was previously reported to be a quantitative variant based on studies of crude tissue preparations. The molecular aberrations were characterized by slow mobility upon electrophoresis, abnormal kinetics for phosphoenolpyruvate, and low affinity for anti-human erythrocyte PK serum. The mutant PK L was similar both electrophoretically and immunologically to PK R.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 984043      PMCID: PMC1685104     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  PYRUVATE KINASE: MOLECULAR DIFFERENCES BETWEEN HUMAN RED CELL AND LEUKOCYTE ENZYME.

Authors:  R D KOLER; R H BIGLEY; R T JONES; D A RIGAS; P VANBELLINGHEN; P THOMPSON
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1964

2.  A specific erythrocyte glycolytic enzyme defect (pyruvate kinase) in three subjects with congenital non-spherocytic hemolytic anemia.

Authors:  W N VALENTINE; K R TANAKA; S MIWA
Journal:  Trans Assoc Am Physicians       Date:  1961

3.  Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies.

Authors:  K Imamura; T Tanaka
Journal:  J Biochem       Date:  1972-06       Impact factor: 3.387

4.  Atypical pyruvate kinase in a patient with haemolytic anaemia.

Authors:  N J Brandt; H K Hanel
Journal:  Scand J Haematol       Date:  1971

5.  A new type of pyruvate-kinase deficiency of human erythrocytes.

Authors:  G W Löhr; K G Blume; H W Rüdiger; G Sokal; E Gulbis
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

6.  Electrophoretic and kinetic studies of mutant erythrocyte pyruvate kinases.

Authors:  K Nakashima; S Miwa; S Oda; T Tanaka; K Imamura
Journal:  Blood       Date:  1974-04       Impact factor: 22.113

7.  A mutant of human red cell pyruvate kinase with high affinity for phosphoenolpyruvate.

Authors:  P Boivin; C Galand
Journal:  Enzyme       Date:  1974

8.  Studies on pyruvate kinase (PK) deficiency. I. Clinical, hematological and erythrocyte enzyme studies.

Authors:  S Miwa; T Nishina
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1974-02

9.  Studies on pyruvate kinase (PK) deficiency. II. Electrophoretic, kinetic and immunological studies on pyruvate kinase of erythrocytes and other tissues.

Authors:  K Imamura; T Tanaka; T Nishina; K Nakashima; S Miwa
Journal:  J Biochem       Date:  1973-12       Impact factor: 3.387

10.  Investigations of the kinetics of red cell pyruvate kinase in normal individuals and in a patient with pyruvate kinase deficiency.

Authors:  U Wiesmann; O Tönz
Journal:  Nature       Date:  1966-02-05       Impact factor: 49.962

View more
  4 in total

1.  A red cell pyruvate kinase mutant with normal L-type PK in the liver.

Authors:  J Etiemble; C Picat; P Boivin
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

2.  The Pk-3 gene determines both the heart, M1, and the kidney, M2, pyruvate kinase isozymes in the mouse; and a simple electrophoretic method for separating phosphoglucomutase-3.

Authors:  J Peters; S J Andrews
Journal:  Biochem Genet       Date:  1984-12       Impact factor: 1.890

3.  An allele (Pk-1b) from wild-caught mice that affects the activity and kinetics of erythrocyte and liver pyruvate kinase.

Authors:  K J Moore; G Bulfield
Journal:  Biochem Genet       Date:  1981-08       Impact factor: 1.890

4.  Human liver type pyruvate kinase: complete amino acid sequence and the expression in mammalian cells.

Authors:  K Tani; H Fujii; S Nagata; S Miwa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.